{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.4062.4062",
    "article_title": "Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study ",
    "article_date": "December 7, 2017",
    "session_type": "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma\u2014Clinical Studies: Poster III",
    "abstract_text": "Background and Purpose Splenectomy, as well as immunotherapy with Rituximab, provides a quick palliation in patients with SMZL, despite being unable to achieve cure. Thus systemic chemotherapy is ultimately required in most cases where it has been demonstrated effective although burdened by substantial toxicity. The IELSG-36 phase II study investigated the efficacy and safety of the association of Rituximab with Bendamustine as the first line treatment of non splenectomized SMZL patients. Patients and Methods The IELSG-36 is an open-label, single arm phase II study designed according to Simon's two-stage method. The primary end point was complete response rate (CRR). Seventy-eight SMZL patients showing active symptomatic disease were registered at 30 centers in Italy and France. In 56 patients (71.8%) the diagnosis was confirmed on central revision and the patients were addressed to treatment with Bendamustine (90 mg/m2 day 1-2) and Rituximab 375 mg/m2 day 1 q28 for six cycles. Results CRR and Overall Response Rate were 61% and 91%, respectively. With a median observation time of 30 months, 3-yr OS, PFS and DOR were 95% (95CI 81-98), 89% (95CI 75-95) and 93% (95CI 80-98), respectively. The recorded toxicity was mild, mostly hematological, and mainly reported during the first three cycles, although an exception G>3 neutropenia evenly occurred during the whole treatment course. Conclusions Bendamustine in association with Rituximab is effective and well tolerated as first line immuno-chemotherapy regimen for non splenectomised SMZL. The favorable toxicity profile suggests the choice of this regimen when an association of chemotherapy with Rituximab is deemed to be used for high risk, heavily symptomatic non splenectomized SMZL patients. Disclosures Haioun: PFIZER: Consultancy, Honoraria; GILEAD: Consultancy, Honoraria; JANSSEN: Consultancy, Honoraria; Sandoz: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; Roche: Consultancy, Honoraria. Re: Gilead: Membership on an entity's Board of Directors or advisory committees. Zucca: Celgene: Honoraria, Research Funding; Celltrion Healthcare: Consultancy, Other: Advisory Role; Bayer: Consultancy, Other: Advisory Role; Takeda: Consultancy, Other: Advisory role; Sandoz: Consultancy, Other: Advisory role; Gilead Science: Consultancy, Other: Advisory role; Jannsen: Consultancy, Honoraria, Other: Advisory role; Gilead Science: Consultancy, Other: Advisory role; Sandoz: Consultancy, Other: Advisory role; Takeda: Consultancy, Other: Advisory role; Celltrion Healthcare: Consultancy, Other: Advisory Role; Roche: Honoraria, Research Funding; Roche: Advisory role, Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Bayer: Consultancy, Other: Advisory Role; Jannsen: Consultancy, Honoraria, Other: Advisory role; Mundipharma: Research Funding; Mundipharma: Research Funding. Federico: takeda: Honoraria, Research Funding. Thieblemont: Janssen: Consultancy; Roche: Consultancy, Honoraria, Research Funding; Bayer: Consultancy, Honoraria; Celgene: Consultancy, Honoraria; Abbvie: Consultancy, Honoraria.",
    "topics": [
        "bendamustine",
        "phase 2 clinical trials",
        "rituximab",
        "splenic marginal zone b-cell lymphoma",
        "toxic effect",
        "chemotherapy regimen",
        "cancer immunotherapy",
        "complete remission",
        "immunotherapy",
        "neutropenia"
    ],
    "author_names": [
        "Emilio Iannitto, MD",
        "Monica Bellei, MSc, PhD",
        "Andr\u00e9s J M Ferreri, MD",
        "Luigi Marcheselli, MS",
        "Marina Cesaretti, MD",
        "Corinne Haioun",
        "Salvatrice Mancuso",
        "Krimo Bouabdallah, MD",
        "Remy Gressin, MD",
        "Claudio Tripodo, MD",
        "Alexandra traverse-Glehen, MD PhD",
        "Lucile Baseggio, MD",
        "Simonetta Zupo",
        "Caterina Stelitano",
        "Barbara Castagnari, MD",
        "Caterina Patti, MD",
        "Francesco Merli",
        "Anna Marina Liberati, MD",
        "Michele Merli",
        "Guido Gini",
        "Maria Giuseppina Cabras",
        "Jehan Dupuis, MD",
        "Francesca Re",
        "Emanuele Zucca, MD",
        "Massimo Federico, MD",
        "Catherine Thieblemont, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Emilio Iannitto, MD",
            "author_affiliations": [
                "Department of Oncology - Division of Hematology, University Hospital Paolo Giaccone,, Palermo, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Monica Bellei, MSc, PhD",
            "author_affiliations": [
                "Department of Diagnostic, Clinical, and Public Health Medicine, University of Modena, Modena, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andr\u00e9s J M Ferreri, MD",
            "author_affiliations": [
                "Unit of Lymphoid Malignancies, IRCCS San Raffaele Scientific Institute, Milano, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luigi Marcheselli, MS",
            "author_affiliations": [
                "Modena Cancer Center, Department of Oncology and Hematology, Modena, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marina Cesaretti, MD",
            "author_affiliations": [
                "Diagnostic Medicine and Pulic Health, University of Modena and Reggio Emilia,, Modena, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Corinne Haioun",
            "author_affiliations": [
                "Lymphoid malignancies unit, University Hospital Henri Mondor, Creteil, France "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Salvatrice Mancuso",
            "author_affiliations": [
                "Policlinico Paolo Giaccone UOC of Hematology, University Hospital, Palermo, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Krimo Bouabdallah, MD",
            "author_affiliations": [
                "University Hospital of Bordeaux, Pessac, France "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Remy Gressin, MD",
            "author_affiliations": [
                "Hematology and Oncology Department, University Hospital, Grenoble, France "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Claudio Tripodo, MD",
            "author_affiliations": [
                "Department of Health Science, Human Pathology Section,Tumor Immunology Unit, University of Palermo, Palermo, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alexandra traverse-Glehen, MD PhD",
            "author_affiliations": [
                "Centre Hospitalier Lyon sud service d anatomie pathologique, Universit\u00e9 Lyon 1, Pierre Benite, France "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lucile Baseggio, MD",
            "author_affiliations": [
                "Centre Hospitalier Lyon Sud, Universit\u00e9 Lyon 1, Pierre Benite, France "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Simonetta Zupo",
            "author_affiliations": [
                "Molecular Diagnostic Unit, IRCCS, AOU San Martino, Genova, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Stelitano",
            "author_affiliations": [
                "Division of Hematology, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Barbara Castagnari, MD",
            "author_affiliations": [
                "UOC of Hematology, Hospital Santa Maria delle Croci, Ravenna, Italy "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Patti, MD",
            "author_affiliations": [
                "Division of Hematology, Azienda Villa Sofia-Ospedali Riuniti Cervello, Palermo, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesco Merli",
            "author_affiliations": [
                "Arcispedale Santa Maria Nuova, UOC of Hematology, AUSL Reggio Emilia/IRCCS, Reggio Emilia, Italy "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Marina Liberati, MD",
            "author_affiliations": [
                "Oncology-Hematology, Hospital AO Santa Maria, Terni, Italy "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Merli",
            "author_affiliations": [
                "Division of Hematology, Ospedale di Circolo & Fondazione Macchi, Varese, Italy "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guido Gini",
            "author_affiliations": [
                "Division of Hematology, Ospedali Riuniti, Ancona, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Giuseppina Cabras",
            "author_affiliations": [
                "Division of Hematology, Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy, Cagliari, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jehan Dupuis, MD",
            "author_affiliations": [
                "Lymphoid malignancies unit, Henri Mondor Hospital, Creteil, France "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Re",
            "author_affiliations": [
                "Ematologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emanuele Zucca, MD",
            "author_affiliations": [
                "IOSI, Oncology Institute of Southern Switzerland and IOR, Institute of Oncology Research, Bellinzona, Switzerland "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Federico, MD",
            "author_affiliations": [
                "University of Modena and Reggio Emilia, Modena, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Catherine Thieblemont, MD",
            "author_affiliations": [
                "CHU Paris-GH St-Louis Lariboisiere F. Widal-Hopital, Saint Louis, Paris, France"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-09T04:07:37",
    "is_scraped": "1"
}